Smith et al.’s longitudinal 5-HT PET study indicated that PD patients with an annual raphe SERT binding decline exceeding 8% have a 2.5-fold increased risk of developing MCI within 2 years (21). This evidence concerns the gene SLC6A4 and Parkinson disease.